Genetic mechanisms in aspirin-induced asthma

American Journal of Respiratory and Critical Care Medicine

Volumn 161, Issue 2 II, 2000, Pages

  Szczeklik, Andrzej ^a   Sanak, Marek ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID;

ALLELE; ASTHMA; BRONCHOSPASM; GENE OVEREXPRESSION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; HUMAN; PRIORITY JOURNAL; PROMOTER REGION; REVIEW;

EID: 0034055932     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.161.supplement_1.ltta-28     Document Type: Review

References (34)

1. Samter, M., and R. F. Beers. 1968. Intolerance to aspirin: clinical studies and consideration of its pathogenesis. Ann. Intern. Med. 68:975-983.
2. Stevenson, D. D. 1984. Diagnosis, prevention and treatment of adverse reactions to aspirin and nonsteroidal anti-inflammatory drugs. J. Allergy Clin. Immunol. 74:617-622.
3. Szczeklik, A. 1992. Aspirin-induced asthma. In J. R. Vane and R. M. Botting, editors. Aspirin and Other Salicylates. Chapman & Hall Medical, London. 548-575.
4. Shuaib Nasser, S. M., and T. H. Lee. 1998. Leukotrienes in aspirin-sensitive asthma. In A. Szczeklik, R. J. Gryglewski, and J. R. Vane, editors. Eicosanoids, Aspirin and Asthma. Marcel Dekker, New York. 317-336.
5. Marquette, C. H., F. Saulnier, O. Leroy, B. Wallaert, C. Chopin, J. M. Demarcq, A. Durocher, and A. B. Tonnel. 1992. Long-term prognosis for near-fatal asthma: a 6-year follow-up study of 145 asthmatic patients who underwent mechanical ventilation for near-fatal attack of asthma. Am. Rev. Respir. Dis. 146:76-81.
6. Bochenek G., E. Nizankowska, and A. Szczeklik. 1996. Atopy trait in hypersensitivity to nonsteroidal anti-inflammatory drugs. Allergy 51:16-23.
7. Lockey, R. F., D. L. Rucknagel, and N. A. Vanselow. 1973. Familial occurrence of asthma, nasal polyps and aspirin-intolerance. Ann. Intern. Med. 78:57-63.
8. Miller, F. F. 1971. Aspirin-induced bronchial asthma in sisters. Ann. Allergy 29:263-265.
9. von Maur, K., N. F. Adkinson, Jr., T. E. Van Metrer, Jr., D. G. Marsh, and P. S. Norman. 1974. Aspirin intolerance in a family. J. Allergy Clin. Immunol. 54:380-395.
10. Delaney, J. C. 1973. Asthma, nasal polyposis, and aspirin sensitivity. Ann. Intern. Med. 79:761-764.
11. Szczeklik, A., and E. Nizankowska. 1983. Asthma improved by aspirin-like drugs. Br. J. Dis. Chest 25:533-543.
12. Nizankowska, E., M. Duplaga, G. Bochenek, and A. Szczeklik. 1998. Clinical course of aspirin-induced asthma: results of AIANE. In A. Szczeklik, R. J. Gryglewski, and J. R. Vane, editors. Eicosanoids, Aspirin and Asthma. Marcel Dekker, New York. 451-472.
13. Duplaga, M. 1998. Clinical picture of aspirin-induced asthma, Ph.D. thesis. Jaggiellonian University, Kraków, Poland.
14. Nasser, S. M. S., R. Pfister, P. E. Christie, A. R. Sousa, J. Barker, M. Schmitz-Schumann, and T. H. Lee. 1996. Inflammatory cell populations in bronchial biopsies from aspirin-sensitive asthmatic subjects. Am. J. Respir. Crit. Care Med. 153:90-96.
15. Sampson, A. P., A. S. Coburn, K. Sladek, L. Adamek, E. Nizankowska, A. Szczeklik, B. K. Lam, J. F. Penrose, K. F. Austen, and S. T. Holgate. 1997. Profound overexpression of leukotriene C4 synthase in aspirin-intolerant asthmatic bronchial biopsies. Int. Arch. Allergy Immunol. 113:355-357.
16. Cowburn, A. S., K. Sladek, J. Soja, L. Adamek, E. Nizankowska, A. Szczeklik, B. K. Lam, J. F. Penrose, K. F. Austen, S. T. Holgate, and A. P. Sampson. 1998. Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J. Clin. Invest. 101:1-13.
17. Szczeklik, A. 1988. Aspirin-induced asthma as a viral disease. Clin Allergy 18:15-20.
18. Szczeklik, A. 1997. Mechanism of aspirin-induced asthma. Allergy 52:613-619.
19. Szczeklik, A., R. J. Gryglewski, and G. Czerniawska-Mysik. 1975. Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients. Br. Med. J. 1:67-69.
20. Szczeklik, A. 1990. The cyclooxygenase theory of aspirin-induced asthma. Eur. Respir. J. 3:588-593.
21. Szczeklik, A., K. Sladek, R. Dworski, E. Nizankowska, J. Soja, J. R. Sheller, and J. A. Oates. 1996. Bronchial aspirin challenge causes specific eicosanoid response in aspirin sensitive asthmatics. Am. J. Respir. Crit. Care Med. 154:1608-1614.
22. Israel, E., A. R. Fischer, M. A. Rosenberg, C. M. Lilly, J. C. Callery, J. Shapiro, P. Rubin, and J. M. Drazen. 1993. The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin. Am. Rev. Respir. Dis. 148:1447-1451.
23. Dahlén, S.-E., and M. Kumlin. 1998. Can asthma be studied in the urine? Clin. Exp. Allergy 28:129-133.
24. Christie, P. E, P. Tagari, A. W. Hutchinson, S. Charlesson, P. Chee, J. P. Arm, and T. H. Lee. 1991. Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects. Am. Rev. Respir. Dis. 143:1025-1029.
25. Ortolani, C., C. Mirone, A. Fontana, G. C. Folco, A. Miadonna, N. Montalbetti, M. Rinaldi A. Sala, A. Tedeschi, and D. Valente. 1987. Study of mediators of anaphylaxis in nasal wash fluids after aspirin and sodium metabisulfite nasal provocation in intolerant rhinitic patients. Ann. Allergy 59:106-112.
26. Kowalski, M. L., M. Sliwinska-Kowalska, Y. Igarashi, M. V. White, B. Wojciechowska, P. Brayton, H. Kaulbach, J. Rozniecki, and M. A. Kaliner. 1993. Nasal secretions in response to acetylsalicylic acid. J. Allergy Clin. Immunol. 91:580-598.
27. Koshino T., S. Takano, T. Houjo, Y. Sano, K. Kudo, H. Kihara, S. Kitani, T. Takaishi, K. Hirai, K. Ito, and Y. Morita. 1998. Expression of 5-lipoxygenase and 5-lipoxygenase activating protein mRNAs in the peripheral blood leukocytes of asthmatics. Biochem. Biophys. Res. Commun. 247:510-513.
28. In, K. H., K. Asano, D. Beier, J. Grobholz, P. W. Finn, E. K. Silverman, E. S. Silverman, T. Collins, A. R. Fischer, T. P. Keith, K. Serino, S. W. Kim, G. T. De Sanctis, C. Yandava, A. Pillari, P. Rubin, J. Kemp. E. Israel, W. Busse, D. Ledford, J. J. Murray, A. Segal, D. Tinkleman, and J. M. Drazen. 1997. Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription. J. Clin. Invest. 99:1130-1137.
29. Lam, B. K., J. F. Penrose, G. J. Freeman, and K. F. Austen. 1994. Expression cloning of a cDNA for human leukotriene C4 synthase, an integral membrane protein conjugating reduced glutathione to leukotriene A4. Proc. Natl. Acad. Sci. U.S.A. 91:7663-7667.
30. Lam, B. K., and K. F. Austen. 1997. Leukotriene C4 synthase: biochemistry and molecular biology. In S. Holgate and S.-E. Dahlén, editors. SRS-A to Leukotrienes: The Dawning of a New Treatment. Blackwell Science, London. 121-132.
31. Sanak, M., H.-U. Simon, and A. Szczeklik. 1997. Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma. Lancet 350:1599-1600.
32. Sanak, M., S. Bazan-Socha, and A. Szczeklik. 1998. Leukotriene C4 synthase (LTC4s.) expression in blood eosinophils of patients with asthma. Eur. Respir. J. 12(Suppl. 28):373s.
33. Sanak, M., and A. Szczeklik. 1998. Leukotriene C4 synthase promoter polymorphism in bronchial asthma. Allergy 53(Suppl. 43):112-113.
34. Szczeklik, A., M. Sanak, E. Nizankowska, L. Mastalerz, G. Bochenek, G. Pulka, and A. Bestynska. 1998. Leukotriene C4 synthase genetic polymorphism directs urinary cysteinyl-leukotriene response to aspirin challenge in asthma. Allergy 53(Suppl. 43):61.